Cargando…

Preoperative Neutrophil: Lymphocyte Ratio, Platelet: Lymphocyte Ratio, and C-Reactive Protein Levels Predictive Value in Determining the Severity of Breast Mass

BACKGROUND & OBJECTIVE: Female breast cancer is one of the most prevalent malignancies among women. The critical step in management of breast cancer is an accurate diagnosis. Hence, peripheral blood-based tests would be one of the most favorable and less invasive methods to study. Recent studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Alizamir, Aida, Dehghan Azad, Sakineh, Pirdehghan, Azar, Moradi, Arash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iranian Society of Pathology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745750/
https://www.ncbi.nlm.nih.gov/pubmed/36532648
http://dx.doi.org/10.30699/IJP.2022.539042.2727
_version_ 1784849215249186816
author Alizamir, Aida
Dehghan Azad, Sakineh
Pirdehghan, Azar
Moradi, Arash
author_facet Alizamir, Aida
Dehghan Azad, Sakineh
Pirdehghan, Azar
Moradi, Arash
author_sort Alizamir, Aida
collection PubMed
description BACKGROUND & OBJECTIVE: Female breast cancer is one of the most prevalent malignancies among women. The critical step in management of breast cancer is an accurate diagnosis. Hence, peripheral blood-based tests would be one of the most favorable and less invasive methods to study. Recent studies have investigated the inflammatory parameters such as neutrophil: lymphocyte ratio (NLR), the platelet: lymphocyte ratio (PLR), and the C-reactive protein (CRP) levels. The elevation in mentioned parameters was proposed as a key factor in cancer progression. The main goal of this study was to investigate the association of NLR, PLR, and CRP levels in patients with breast lesions. METHODS: The NLR, PLR, and CRP levels were calculated from 200 female patients presenting with either benign or malignant lesions. RESULTS: The cut-off values of NLR, PLR, and CRP were 1.24, 96, and 10.36 mg/L, respectively. A significant difference in NLR (P<0.001), PLR (P<0.001), and CRP levels (P<0.001) were observed between the two major studied cohorts. CONCLUSION: Elevated NLR, PLR, and CRP levels could predict the presence of malignancy. In addition to the low cost and properties of the mentioned methods, utilization of this data could facilitate and improve clinical decision-making for treatment.
format Online
Article
Text
id pubmed-9745750
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Iranian Society of Pathology
record_format MEDLINE/PubMed
spelling pubmed-97457502022-12-16 Preoperative Neutrophil: Lymphocyte Ratio, Platelet: Lymphocyte Ratio, and C-Reactive Protein Levels Predictive Value in Determining the Severity of Breast Mass Alizamir, Aida Dehghan Azad, Sakineh Pirdehghan, Azar Moradi, Arash Iran J Pathol Original Article BACKGROUND & OBJECTIVE: Female breast cancer is one of the most prevalent malignancies among women. The critical step in management of breast cancer is an accurate diagnosis. Hence, peripheral blood-based tests would be one of the most favorable and less invasive methods to study. Recent studies have investigated the inflammatory parameters such as neutrophil: lymphocyte ratio (NLR), the platelet: lymphocyte ratio (PLR), and the C-reactive protein (CRP) levels. The elevation in mentioned parameters was proposed as a key factor in cancer progression. The main goal of this study was to investigate the association of NLR, PLR, and CRP levels in patients with breast lesions. METHODS: The NLR, PLR, and CRP levels were calculated from 200 female patients presenting with either benign or malignant lesions. RESULTS: The cut-off values of NLR, PLR, and CRP were 1.24, 96, and 10.36 mg/L, respectively. A significant difference in NLR (P<0.001), PLR (P<0.001), and CRP levels (P<0.001) were observed between the two major studied cohorts. CONCLUSION: Elevated NLR, PLR, and CRP levels could predict the presence of malignancy. In addition to the low cost and properties of the mentioned methods, utilization of this data could facilitate and improve clinical decision-making for treatment. Iranian Society of Pathology 2022 2022-09-02 /pmc/articles/PMC9745750/ /pubmed/36532648 http://dx.doi.org/10.30699/IJP.2022.539042.2727 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution- 4.0 International License (https://creativecommons.org/licenses/by/4.0/) which permits Share, copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, even commercially.
spellingShingle Original Article
Alizamir, Aida
Dehghan Azad, Sakineh
Pirdehghan, Azar
Moradi, Arash
Preoperative Neutrophil: Lymphocyte Ratio, Platelet: Lymphocyte Ratio, and C-Reactive Protein Levels Predictive Value in Determining the Severity of Breast Mass
title Preoperative Neutrophil: Lymphocyte Ratio, Platelet: Lymphocyte Ratio, and C-Reactive Protein Levels Predictive Value in Determining the Severity of Breast Mass
title_full Preoperative Neutrophil: Lymphocyte Ratio, Platelet: Lymphocyte Ratio, and C-Reactive Protein Levels Predictive Value in Determining the Severity of Breast Mass
title_fullStr Preoperative Neutrophil: Lymphocyte Ratio, Platelet: Lymphocyte Ratio, and C-Reactive Protein Levels Predictive Value in Determining the Severity of Breast Mass
title_full_unstemmed Preoperative Neutrophil: Lymphocyte Ratio, Platelet: Lymphocyte Ratio, and C-Reactive Protein Levels Predictive Value in Determining the Severity of Breast Mass
title_short Preoperative Neutrophil: Lymphocyte Ratio, Platelet: Lymphocyte Ratio, and C-Reactive Protein Levels Predictive Value in Determining the Severity of Breast Mass
title_sort preoperative neutrophil: lymphocyte ratio, platelet: lymphocyte ratio, and c-reactive protein levels predictive value in determining the severity of breast mass
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745750/
https://www.ncbi.nlm.nih.gov/pubmed/36532648
http://dx.doi.org/10.30699/IJP.2022.539042.2727
work_keys_str_mv AT alizamiraida preoperativeneutrophillymphocyteratioplateletlymphocyteratioandcreactiveproteinlevelspredictivevalueindeterminingtheseverityofbreastmass
AT dehghanazadsakineh preoperativeneutrophillymphocyteratioplateletlymphocyteratioandcreactiveproteinlevelspredictivevalueindeterminingtheseverityofbreastmass
AT pirdehghanazar preoperativeneutrophillymphocyteratioplateletlymphocyteratioandcreactiveproteinlevelspredictivevalueindeterminingtheseverityofbreastmass
AT moradiarash preoperativeneutrophillymphocyteratioplateletlymphocyteratioandcreactiveproteinlevelspredictivevalueindeterminingtheseverityofbreastmass